CBS NEWS: Woman says her son couldn't afford his insulin – now he's dead

When Nicole Smith-Holt's 26-year-old son died, he had just moved out of his parents' home and was starting a life of his own.

HEALIO/ENDOCRINE TODAY: Sandoz, Gan & Lee enter agreement to market insulin biosimilars

Sandoz on Wednesday announced an agreement with Gan & Lee Pharmaceuticals to commercialize biosimilar versions of insulins used to treat patients with type 1 and type 2 diabetes.

BOSTON 25 NEWS: Spiking insulin costs causing dangerous behavior in diabetics

Christopher Noble is one of 7 million Americans who need insulin to manage their diabetes.

VALLEY NEWS: Rising drug prices hurt local families

More than 7-million Americans need insulin to live. But insulin prices have nearly tripled since 2002, causing some patients to go to extreme lengths to afford their medication.

THE WALL STREET JOURNAL: Insulin Quest: When Lifesaving Drugs Are Out of Reach

Nearly one in 10 Americans has diabetes. But because of rising insulin prices many of them struggle to afford the drugs they need and some diabetics ration their dosage.

USA TODAY: Lack of insulin could affect 40 million people with diabetes by 2030, study finds

Insulin use is expected to rise 20 percent by 2030, and many people who need it for Type 2 diabetes won't have access, a study from Stanford University suggests.

American Diabetes Association® Reaffirms Commitment to Insulin Access and Affordability for All—Transparency on Insulin Pricing Critical

More than 400,000 individuals have signed the ADA’s Make Insulin Affordable petition, as the ADA marks second anniversary of the initiative.

THE HILL: Congressional report says insulin market benefits drugmakers and insurers, not patients

“Perverse” incentives in the insulin supply chain lead to artificially high prices, as well as limited competition in the markets, according to a bipartisan report released Thursday by two lawmakers.

HEALTHLINE: Why Is the Cost of Insulin Rising and What Can People Do About It?

Insulin in the United States isn’t free — in fact, it’s remarkably expensive, with some of today’s newest varieties costing over $500 for a box of five pens, according to GoodRx.

CBS NY: Illegal Insulin: Desperate Diabetes Patients Turn To Black Market For Affordable Drugs

After years of rising insulin prices, a growing number of diabetics and their families are now facing some tough choices when it comes to paying for the drug.

THE PHILADELPHIA INQUIRER: UnitedHealthcare gives 20-year guarantee to boy’s insulin coverage after Inquirer article

Insurance companies commonly switch up which brand of medication is considered their preferred option. Before the plan will pay for a more expensive brand, patients must prove the lower-cost option doesn't work for them.

Americans Rationing Insulin As Prices Skyrocket

26-year-old Alec Smith couldn’t afford the $1,300 a month insulin…

KCTVNEWS5: Kansas City college student describes the copay that almost killed her

The price of insulin has skyrocketed, and what some diabetics do to get the medicine they need is simply heartbreaking and awful.

MEDICAL PRESS: ncreasing cost of insulin has serious health consequences

The increasing cost of insulin is potentially exposing those with diabetes to serious health consequences, according to an American Diabetes Association statement published in the June issue of Diabetes Care.

WCVB5: Mom Fighting to Save Daughter: Big Pharma Can’t Hold You Hostage

Her daughter’s lifesaving medication used to be affordable, just $50 for a three-month supply. Today, it costs $1300.

ALLIGATOR: UF holds forum on insulin prices

Sydney Look was diagnosed with Type 1 diabetes when she was 16 years old. The condition causes her pancreas to produce little to no insulin.

YAHOO LIFESTYLE: Mother shares the outrageous cost of insulin for her daughter

The problem arose when Doreen Rudolph’s daughter, Nicole, turned 26 last year. The grad school student was no longer covered under her parents’ insurance.

A SWEET LIFE: Why is Insulin So Expensive in America?

I was stuck for many years pushing paperwork in a miserable job that I hated. Why did I stay? Because I needed insurance to afford diabetes test strips, a glucose meter, an insulin pump, all the supplies to make it infuse insulin into my body, and insulin.

HEALTHLINE: The High Cost of ‘Insurance Gaps’ If you Have Diabetes

Researchers say 1 in 4 people with type 1 diabetes go at least 30 days without health coverage.

U.S. NEWS: Insulin Costs Are Skyrocketing. This Is Why

According to the Centers for Disease Control and Prevention, more than 30 million Americans have diabetes – representing nearly 10 percent of our population.

THE INQUIRER (PHILADELPHIA): High insulin costs have diabetes patients, doctors scrambling for answers

When his type 1 diabetes patients can’t keep up with the high cost of insulin, Mark Schutta half-jokingly offers a radical solution: Buy an off-season ticket to France.

DIABETES.CO.UK: US government urged to cap soaring insulin costs

The US government is being urged to take action over soaring insulin prices in America.

MEDICAL BAG: AMA: Federal Government Must Tackle Rising Insulin Prices

U.S. officials need to take action to control spiking insulin prices, the American Medical Association (AMA) says.

CW39 HOUSTON: Nearly half of diabetics skimp on treatment due to high insulin cost

Almost half of diabetics in America have cut back on treatment at some point due to the price of insulin hitting new heights.

CBS: Study: Almost half of the diabetics skip medical care due to costs

Almost half of diabetics are cutting back on treatment because of costs, according to a new survey that comes as the skyrocketing price of insulin is prompting lawmakers and physicians to call for more oversight.

MANAGED CARE: Nevada Pushes for Transparency On Diabetes Drug Prices

As rising drug prices became a hot political issue, Yvanna Cancela was looking for a way to make a difference. So early last year, the Nevada state senator introduced a transparency bill that would require drugmakers to report pricing, costs, and rebates—but only concerning diabetes medications.

DIABETES HEALTH: Researchers Examine the Cost of Diabetes in the U.S. in 2017

According to a new study completed by the American Diabetes Association, the total cost of diagnosed diabetes for 2017 was estimated at $327 billion.

CLINICAL ADVISOR: Improving Insulin Access: ADA Public Policy Recommendations

The American Diabetes Association (ADA) has issued a public policy statement that outlines long- and short-term recommendations for improving insulin affordability.

MEDICAL XPRESS: A young life lost to high insulin prices

Alec Smith was diagnosed with type 1 diabetes shortly before his 24th birthday. When he turned 26, he lost his health insurance. Less than a month later, he lost his life because he couldn't afford the exorbitant price of his life-saving insulin.

AJMC: ADA Issues Recommendations Designed to Fix Insulin Pricing, Accessibility Crisis

The American Diabetes Association (ADA) released a set of policy recommendations designed to spotlight the increasing difficulties patients with diabetes have affording insulin or gaining access to the life-saving medication through health insurance.

MEDSCAPE: ADA Issues Recommendations to Improve Insulin Access

In a new policy statement, the American Diabetes Association (ADA) provides specific short- and long-term recommendations for improving insulin access and affordability.

WGRZ (NBC BUFFALO): Coping with rising insulin costs

Jack Lafferty has needed insulin for about 10 years. With insulin prices skyrocketing in the U.S., it’s taking a toll on monthly medical bills.

ENDOCRINOLOGY ADVISOR: ADA Issues White Paper Addressing Escalating Cost of Insulin

The increasing cost and access to insulin has become a great concern to individuals with diabetes, as well as all other stakeholders, including families, healthcare providers, insurers, and employers, and the American Diabetes Association (ADA) has now issued a white paper addressing the subject.

KFVS 12 (CBS): Can’t afford your diabetes care?

More than 100 million Americans live with diabetes or pre-diabetes according to the CDC, and some can’t afford the testing supplies and medication they need to live healthy lives.

STAT NEWS: Paying the price for insulin

The debate about drug costs can be hard to follow because it is both broad and deep. Between patients not being able to afford their medication, the role of “middlemen” (pharmacy benefit managers), and lawyers filing class-action lawsuits, the topic is complex and can be emotional for many.

THE WESTERN JOURNAL: Mom Begging for Lower Insulin Prices After Son Dies Rationing His Medication

Alec Raeshawn Smith, 26, was trying to hold out for payday so he could afford to pick up his insulin prescription. But Smith, a type 1 diabetic, was found dead in his apartment before payday arrived.

CHICAGO TRIBUNE: Son’s death pushes Minnesota mom into fight against high, rising drug prices

When Alec Smith turned 26 last May and aged out of his parents' health insurance, he discovered that he couldn't afford coverage of his own. Within weeks, he was trying to ration his diabetes medication because he couldn't afford a $1,300 refill.

NEWSMAX: Diabetes Takes a Toll on Your Wallet as Well as Your Health

When we think of diabetes, what comes to mind is diet, insulin injections, obesity, and even heart disease. But diabetes doesn’t just affect a person’s health; it can be incredibly expensive.

THE HILL: Diabetes research at risk due to funding lapse, groups warn

Several groups are pleading with Congress to permanently fund diabetes programs, arguing the absence of long-term funding could delay promising new research and harm prevention efforts in vulnerable populations.   

KECI: Specialist warns diabetes is dealing Montana a powerful blow

Figures from the American Diabetes Association and Providence Health Services show diabetes is dealing Montana a powerful blow.

Fox Business: HHS Nominee Oversaw Big Drug Price Increases at Lilly

President Donald Trump said in a tweet Monday that his nominee for secretary of Health and Human Services will be a "star" for his ability to lower drug prices.

Drug Topics: As Diabetes Numbers Rise, Costs Mount

Diabetes treatment has seen sweeping changes in recent years, as more patients are diagnosed, and as the estimated cost to Americans—$245 billion in 2012—continues to rise.

News-Press: Growing problem: Diabetes in children puts a strain on families, pocketbooks

Josiah Lawrence thinks he’s pretty normal.

Houma Today: Federal and state probes target rising cost of diabetes drugs

With the price of a crucial diabetes drug skyrocketing, at least five states and a federal prosecutor are demanding information from insulin manufacturers and the pharmaceutical industry’s financial middlemen.

Nuvo: Indiana has a drug (company) problem: Insulin is increasingly inaccessible for those who need it

It is a bright and sunny autumn Saturday afternoon. Across Indiana, people gather on the sidelines of kids’ soccer games and tailgate outside of college football stadiums.

Healthcare Finance: Soaring insulin prices prompt federal and state investigations into drugmakers, pharma

With the price of a crucial diabetes drug skyrocketing, at least five states and a federal prosecutor are demanding information from insulin manufacturers and the pharmaceutical industry's financial middlemen.

WJTV 12: Diabetes supply cost puts strain on patients and companies

Experts say increasing diabetes supply cost is putting a strain on patients and companies.

News Press Now: Insulin costs burdening patients

Ever-increasing costs for lifesaving insulin are starting to fuel desperation among at least a portion of those with Type-1 diabetes.

WWLP 22 News: The high price of staying alive

The EpiPen isn’t the only drug that’s seen a massive price hike in recent months.

New Jersey 101.5: ‘It is crippling’ — NJ diabetics struggling to afford insulin

Debbie Remsen and her husband both have decent-paying jobs, and her insurance plan through work is no worse than the plans of most New Jersey residents.

Newsday: Insulin illustrates health care woes

In 1923, the three inventors of insulin sold the patent to the University of Toronto for $1 each.

The Washington Post: Absent federal action, states take the lead on curbing drug costs

Lawmakers in Maryland are daring to legislate where their federal counterparts have not.

The Lansing Star: Next Steps In Federal Insulin Price Inquiry

The co-chairs of the Congressional Diabetes Caucus, Tom Reed (R-NY), Reps. Diana DeGette (D-CO) are taking next steps in their inquiry into the rising price of insulin after meetings during the past two months with stakeholders at major trade associations and in the diabetes community.

American Pharmacists Association: Rising Cost of Insulin Leads Diabetics to Take Dangerous Risks

The population of Americans affected by type 1 and type 2 diabetes has grown over the years—to 29 million today.

Bloomberg: Drug Plans Are Fighting States to Keep Prices in the Dark

California is the biggest state so far to seek to pull back the curtain on pharmacy-benefits managers, as the industry aggressively tries to thwart a wider push for transparency.

Indy Star: 'An escalating crisis': People with diabetes struggle to afford life-saving insulin

​​​​​​For the first two decades that Jessica Price had diabetes, she never worried about the price of her insulin and supplies, since her mother’s insurance covered the cost.

KAAL TV: Mother Says She Lost Her Son Because He Couldn't Afford Insulin

"On June 27th at 5:20 I received a phone call from his girlfriend saying that she had found him dead in his apartment."

STAT News: Insurers can profit while improving the lives of people with type 1 diabetes

As the debate over the future of health care coverage moves in fits and starts, it may seem like any improvements in health care coverage are equally stalled.

The Hill: Who is to blame for skyrocketing drug prices?

Across the board, drug prices are soaring.

Los Angeles Times: Yes, we can lower sky-high drug prices — other countries have done it

Scott Gottlieb, head of the Food and Drug Administration, wasted no time in his opening remarks at a forum last week on high drug prices.

Minnesota Public Radio: Klobuchar calls for congressional action to ease insulin prices

The cost of insulin has more than tripled in the last decade, and U.S. Sen. Amy Klobuchar says it's financially squeezing people with diabetes who rely on the drug to regulate their blood sugar.

Business Insider: Americans are facing rising out-of-pocket healthcare costs — here's why

Republican healthcare bills in the House and Senate have people concerned about whether they'll be left uninsured — or underinsured.

Star Tribune: The soaring price of insulin leaves Minnesota diabetics with few good choices

Robert Newton has been taking insulin for years to keep his diabetes in check, but with the medication now costing him $500 a month, there are times when he has no choice but to ration his supply and take less than he should.

Washington Post: Nevada’s insulin pricing transparency law is a model for the nation

I applaud the push to rein in insulin prices. In Nevada, we are way ahead of Washington when it comes to sending a message to Big Pharma that enough is enough.

Bloomberg: The Crazy Math Behind Drug Prices

David Hernandez, a 44-year-old restaurant worker and Type 1 diabetic, didn’t have insurance from 2011 through 2014 and often couldn’t afford insulin—a workhorse drug whose list price has risen more than 270 percent over the past decade.

Des Moines Register: Editorial: Being diabetic is becoming unaffordable

Egyptian medical texts dated around 550 B.C. contain the earliest known descriptions of diabetes.

CBS News: Feeling the pain of rising drug prices? Blame the middle man

While Washington wrangles with a replacement for Obamacare, patients across the country continue to battle one of the biggest everyday obstacles to good health care: Rising drug prices.

Washington Post: Insulin is too expensive for many of my patients. It doesn’t have to be.

At age 15, I suddenly felt an unquenchable thirst and began urinating frequently.

Washington Post: Lawmakers make bipartisan push to understand the soaring price of a lifesaving drug

Two lawmakers from opposite sides of the aisle have teamed up to ask three powerful health care industries to explain the rising cost of insulin, an essential treatment for people with diabetes.

CBS News: Black market insulin: What you need to know

Millions of consumers are battling rising drug prices.

Healio: As insulin prices rise, endocrinologists confront growing crisis

The number of Americans with diabetes continues to grow, along with the need for insulin therapy.

Las Vegas Review-Journal: Sandoval signs bill to increase insulin price transparency

Gov. Brian Sandoval signed off on a bill Thursday that requires pharmaceutical companies to release insulin prices, weeks after vetoing a similar bill that he said wasn’t strong enough.

ABC News: Nevada forces drugmakers to reveal insulin pricing, profits

Nevada Gov. Brian Sandoval signed into law Thursday the nation's strictest requirements for pharmaceutical companies to reveal how they set certain prescription drug prices.

Business Insider: Nevada just passed one of the strictest drug pricing transparency laws in the country

The state of Nevada is taking a new approach to tackling the rising price of prescription drugs with a new piece of legislation.

Pittsburgh Post-Gazette: Cost of insulin just one hurdle for seniors with diabetes

Dolores Suvak retired from her job as a high school English teacher in the Woodland Hills School District in 2006 with a generous retirement package that included an additional 10 years of health coverage under her school employees’ plan.

Los Angeles Times: How 'price-cutting' middlemen are making crucial drugs vastly more expensive

Diabetes doctor Irl B. Hirsch has watched with dismay as more of his Seattle-area patients take life-threatening steps to deal with the soaring price of insulin.

Kaiser Health News: Daylight On Diabetes Drugs: Nevada Bill Would Track Insulin Makers’ Profits

Patients notched a rare win over the pharmaceutical industry Monday when the Nevada Legislature revived a bill requiring insulin makers to disclose the profits they make on the life-sustaining drug.

STAT News: Citing cost, WHO rejects request to add some insulins to essential medicines list

In a rebuke to two of the largest diabetes drug makers, the World Health Organization has decided not to include a pair of widely used insulins on its newest list of essential medicines, because the agency determined that the costs did not justify additional benefits.

Los Angeles Times: California bill would end 'purely profit-driven' practice of drug-company coupons

When it comes to fixing the dysfunctional U.S. healthcare system, state Assemblyman Jim Wood (D-Healdsburg) knows there are bigger fish to fry than drug-company discount coupons.

New York Times: Drug Lobbyists’ Battle Cry Over Prices: Blame the Others

Hundreds of independent pharmacists swarmed the House and Senate office buildings one recent afternoon, climbing the marble staircases as they rushed from one appointment to the next, pitching lawmakers on their plan to rein in the soaring drug prices that have enraged American consumers.

U.S. News & World Report: Nevada Senate Passes Insulin-Price Bill Tough on Drugmakers

A bid in Nevada to force America's three insulin manufacturers to turn over information on the drastically increasing prices of what is a life-sustaining hormone treatment for people with diabetes advanced with bipartisan support on Friday.

CBS News: Rising insulin prices have diabetics crying foul

Insulin prices are only getting more painful.

Business Insider: The prices for life-saving diabetes medications have increased again

Insulin prices have been rising — increases that mean some people are spending as much on monthly diabetes-related expenses as their mortgage payment.

The Statehouse File: Rising insulin prices force diabetic Hoosiers to make tough choices

For six years, Erin Roberts worked two jobs in order to afford the life-saving medication her son depended on for survival.

Vox: Insulin price hikes tell us a lot about what's wrong with drug pricing in America

When inventor Frederick Banting discovered insulin in 1923, he refused to put his name on the patent.

NBC News: Patients Beg For Pricey Drugs On Facebook Black Market

Desperate patients are swapping pricey pharmaceutical drugs on Facebook. Doctors say it's dangerous.

CNBC: Eli Lilly raised prices on 9 drugs last week

Indianapolis drug giant Eli Lilly raised list prices of nine of its medicines last week between 6 and 10 percent, according to data obtained by CNBC.

Business Insider: A giant drugmaker just set the strictest price-increase caps of the industry

Drug manufacturers have been feeling the heat over the price increases they make on prescription drugs.

New York Times: Express Scripts to Offer Cheaper Drugs for Uninsured Customers

It is one of the most acute indignities of being uninsured in this country: Those with the least ability to pay are asked to spend the most for their prescription drugs.

Washington Post: Keeping my kids with diabetes alive costs thousands a year. Trumpcare terrifies me.

Last week, the House of Representatives passed the American Health Care Act, which would cut Medicaid considerably and allow insurance companies to charge people with preexisting conditions significantly more for coverage.

Bloomberg: Novo's Legal Challenges Mount as States Query Insulin Prices

Novo Nordisk A/S's legal challenges are mounting in the U.S. as authorities from Washington state to New Mexico question its pricing policies and the Danish drugmaker settles a probe of its marketing practices that allegedly included disguising salespeople as medical educators.

Ukiah Daily Journal: RV resident calls on Congress

On Thursday, March 30, Angela Torres, of Redwood Valley, representing the State of California, met with Sens. Kamala Harris (D-CA) and Dianne Feinstein (D-CA), and Reps. Jared Huffman(CA-02-D), Jerry McNerney(CA-09-D), John Garamendi(CA-03-D), and Doris Matsui (CA-06-D) to raise her voice on behalf of the more than 115 million Americans living with or at risk for diabetes.

FiercePharma: Eli Lilly's insulin pricing scrutiny intensifies with newly disclosed state AG probes

Already under fire for its insulin pricing, Eli Lilly faces a pair of new investigations by state attorneys general.

Modern Healthcare: Two states launch investigation into Eli Lilly's insulin pricing

Two state attorneys general are investigating the pharmaceutical company Eli Lilly's insulin pricing, the company said Monday.

Las Vegas Review-Journal: Nevada coalition works for unprecedented insulin refund law

Aiming to rein in soaring prescription drug prices, an unlikely Nevada coalition is trying to force pharmaceutical companies to disclose how they set insulin prices — and issue refunds to diabetics or their insurance companies if annual price hikes surpass inflation.

Business Insider: One in 7 people in Nevada is living with diabetes, and the state is now pushing a new approach to tackle the cost of treatment

The state of Nevada is taking a new approach to tackling the rising price of prescription drugs with a new bill.

NBC News: Desperate Families Driven to Black Market Insulin

Fourth grader Gabriella Corley is trapped.

Regulatory Affairs Professionals Society: Generic Drug Industry Group Seeks FDA Regulation Changes

The Association of Accessible Medicines (AAM), formerly known as the Generic Pharmaceutical Association, has recommended five major US Food and Drug Administration (FDA) regulation tweaks in a letter to the Department of Commerce.

Vice Media: Nevada Could Deal a Serious Blow to Insulin Manufacturers

Even though insulin access can literally be a case of life or death, awareness about diabetes drug access is often limited among those who don't personally experience the disease or have a friend or family member who does.

Las Vegas Review-Journal: Families who live with diabetes lament medication high costs

Patients and family members of those who suffer from diabetes shared stories of struggle and heartbreak Wednesday and urged support for a bill to rein in the escalating costs of diabetes medication.

STAT: Meet the lawyer trying to pry drug pricing secrets out of Big Pharma

He has a private jet, a pedigree of winning billion-dollar settlements, and the (sometimes grudging) respect of his adversaries.

CNBC: In the debate over rising drug prices, both drugmakers and PBMs claim innocence

The battle over rising drug prices has become a full-blown he-said-she-said.

Public Opinion: Middlemen take big cut as insulin costs triple

The two doctors who discovered insulin almost a century ago made hardly anything when they sold the intellectual property rights of their Nobel Prize-winning medicine to the University of Toronto, making about $14 each in today's money.

ABC 7: Cool kid Aiden Darius promotes diabetic issues in Washington

This week's ABC7 Cool Kid is Aiden Darius, who tutors classmates and is a junior ambassador for the American Diabetes Association.

Men's Health: The Exorbitant Cost of Diabetes Drugs Killed This Man

Just last week, we ran a story on a survey revealing that the richest one percent of Americans live an average of 10 years longer than the poorest one percent.

Healthline: Diabetes Orgs Labor to Tackle Healthcare Reform

The future of healthcare reform remains ever unclear.

Business Insider: People are raising money for routine prescriptions with sites like GoFundMe

Lonnie Cucinitti gets choked up when he thinks about all the people in his life who chipped in when he needed money for his four prescriptions.

BioPharma Dive: Maryland general assembly sends drug price gouging bill to gov.'s desk

Maryland is slated to become the latest state to give its attorney general power to levy civil penalties against "unconscionable" prescription drug price increases.

Nevada Appeal: Professor says capping insulin price doesn’t treat the cause

A professor at Emory College in Atlanta says it's a noble goal to try to slow the rate healthcare costs are rising but that Nevada Senate Bill 265 isn't the answer.

Managed Healthcare Executive: Partnership aims to make insulin more affordable

CVS Health will launch Reduced Rx, a prescription savings program that will offer discounts on certain medications through CVS Health’s pharmacy benefits manager, CVS Caremark directly to patients.

Vice Media: The High Price of Insulin Is Literally Killing People

Shane Patrick Boyle died on March 18th, 2017, from Type I Diabetes.

Concord Monitor: Sen. Maggie Hassan: It’s time to address the skyrocketing cost of prescription drugs

In New Hampshire and across America, the rising costs of prescription drugs are forcing families to make agonizing decisions such as whether to put food on the table or fill a prescription that could improve – or even save – a life.

MedPage Today: ACP: What to Do About the High Price of Drugs?

A lack of price controls, inadequate competition, a small market for agents that treat rare diseases, and even the high cost of research are just some of the reasons for the high price-tags of certain drugs, according to speakers here.

Reno Gazette-Journal: Nevada group wants drugmakers to reimburse diabetics

Nevadans dismayed by soaring drug prices told lawmakers Wednesday the state should take unprecedented action to curb costs.

FiercePharma: Price 'scheme' lawsuit targets CVS, Express Scripts as well as Novo, Lilly, Sanofi

Another legal salvo has been fired against top insulin makers, accusing them of colluding on prices, but this class action suit also targets pharmacy benefit managers CVS, Express Scripts and UnitedHealth’s OptumRx, claiming they were part of the alleged scheme.

Bloomberg BNA: Sanofi, CVS, Others Accused of Insulin Price Fixing

The leading U.S. drugmakers and pharmacy benefit managers colluded to fix prices for insulin, leading to skyrocketing costs and windfall profits for the companies, a new lawsuit alleges.

Modern Healthcare: New PBM programs bypass insurers to offer drug discounts directly to consumers

Pharmacy benefit managers and tech startups are responding to underinsurance and the onslaught of high-deductible health plans by cutting out insurers in the quest to help patients lower their prescription drug costs.

A Sweet Life: Novo Nordisk and CVS Offer Discounted, But Inferior, Insulin

This week, Novo Nordisk and CVS Health announced a new program that will offer discounts on insulin, a life-sustaining drug for people with diabetes.

Business Insider: A drug company just struck a deal to discount the price of a lifesaving diabetes medication to $25

Insulin prices have been rising — increases that mean some people are spending as much on monthly diabetes-related expenses as their mortgage payment.

BioPharma Dive: Bernie Sanders calls for more broadcast news on drug pricing

Sen. Bernie Sanders, I-VT, an outspoken critic of the pharmaceutical industry, lobbed his latest attack on Monday, this time at television news networks for their lack of coverage on rising drug prices.

Bloomberg: Drug CEO Has Problem With U.S. Patients Paying His Prices

Too many diabetics in the U.S. are inadvertently getting stuck with a big bill, making it imperative that drugmakers and middlemen at the heart of the country’s complex pricing system fix the issue before regulators step in, the world’s biggest maker of insulin said.

Foreign Affairs: Making Insulin Affordable

James Elliott is convinced that the statistics describing the prevalence of type 1 diabetes are misleading.

Missoulian: Diabetic will die without health care

I’m a Type 1 diabetic, and I was diagnosed at 13 years old.

KHOU: Cutting prescription drug costs by buying abroad

For underinsured Americans, insurance won’t cover the cost of prescription medications.

Endocrinology Advisor: Rising Insulin Prices: ADA & Endocrine Society Call for Action

Between 2002 and 2013, the number of Americans diagnosed with diabetes increased by approximately 65%, from 13.5 million to 22.3 million.

Daily Mail: Federal lawsuit accuses three insulin manufacturers of conspiring together to raise their prices as research finds cost increased 120% over four years

A federal lawsuit is accusing three of the biggest drug manufacturers of insulin of conspiring together to raise their prices, but the pharmaceutical companies deny the allegations.

CBS News: Lawsuit accuses drug makers of conspiring to hike insulin prices

More than 29 million Americans live with diabetes, and for some six million of them, insulin is a life or death medication. US trial to commence over insulin price hike lawsuit

The increasing cost of insulin is in the spotlight as a "groundbreaking" lawsuit in the US has been filed against three major pharmaceutical companies.

News 4 Tuscon: N4T Investigators: Rapid rise in insulin costs has diabetics looking for answers

It's the seventh leading cause of death in the U.S.

Dayton Daily News: Kettering diabetic on insulin prices: ‘I’m getting gouged’

Tim Rau, 56, of Kettering, has been a diabetic for 15 years and insulin dependent for a decade, but he’s still baffled as to why his Lantus prescription costs so much, can change in price so quickly, and costs a different amount at every pharmacy.

BioPharma Dive: Express Scripts says branded drug prices rose nearly 11% last year

Express Scripts forecasts large spending increases over the next few years for anti-inflammatory, diabetes and oncology drugs, according to a new report.

St. Louis Post-Dispatch: Editorial: Trump must follow tough talk on drug pricing with action

Another runaway drug-pricing problem is putting an easy-to-use version of naloxone, a life-saving drug that can reverse an opioid overdose, out of reach for most drug addicts, their families and first responders.

Sacramento Bee: Diabetes has become one of America’s most expensive diseases

With an estimated 30 million Americans struggling with diabetes, the disease is one of the nation’s most entrenched chronic conditions

Medscape: Diabetes Patients Hit Back: File Suit Against Insulin Companies

A group of diabetes patients have filed a class-action lawsuit in the United States against three insulin manufacturers, Eli Lilly, Novo Nordisk, and Sanofi, alleging that they conspired in an organized scheme to drive up prices.

FiercePharma: Sanofi, Novo and Lilly face class action over 'astounding' insulin price hikes

An “insidious” pricing war has left patients with huge, “devastating” bills for their needed insulins, according to a new class action lawsuit filed against Sanofi, Novo Nordisk and Eli Lilly.

Vox: If Trump wants to lower drug prices, he’s going about it all wrong

Americans are exceptional in many ways — including being number one in the world when it comes to spending on prescription drugs.

New York Times: Trump Vows to Ease Rules for Drug Makers, but Again Zeros In on Prices

President Trump promised some of the nation’s top drug company executives in a meeting at the White House on Tuesday that he would slash regulations at the Food and Drug Administration and make it easier for them to manufacture products in the United States.

BioPharma Dive: Insulin drugmakers sued for inflating prices

A lawsuit filed Monday in Massachusetts district court accused drugmakers Eli Lilly, Novo Nordisk and Sanofi of illegally inflating the list prices for insulin products in a scheme designed to ensure coverage and protect profits.

Business Insider: The makers of insulin are being accused of price-fixing in a class-action lawsuit

A lawsuit filed Monday alleges that the three companies that make insulin have been part of an "organized scheme to drive up prices at the expense of patients who need insulin drugs to live."

Washington Post: Diabetes patients sue insulin makers for ‘pricing fraud’

A group of diabetes patients filed a lawsuit Monday against three drug companies for systematically increasing the list prices of insulin for years in an alleged fraudulent-pricing scheme that saddled patients with “crushing out-of-pocket expenses,” according to the filing.

New York Times: Drug Makers Accused of Fixing Prices on Insulin

A lawsuit filed Monday accused three makers of insulin of conspiring to drive up the prices of their lifesaving drugs, harming patients who were being asked to pay for a growing share of their drug bills.

Business Insider: A huge drugmaker just took an unprecedented move to counter criticism about rising prices

Merck, the giant drug company known for its cancer immunotherapy drug Keytruda and its vaccines business, has published a report that outlined the company's average list price increases for its products.

Business Insider: We asked pharma executives the one question they didn't want to hear about drug pricing

It's shaping up to be another rough year for the drug industry.

Kaiser Health News: Health Law Coverage Has Helped Many Chronically Ill — But Has Still Left Gaps

As President Donald Trump and Republicans in Congress devise a plan to replace the 2010 health law, new research suggests a key component of the law helped people with chronic disease get access to health care — though, the paper notes, it still fell short in meeting their medical needs.

Fox Business: 5 Drugs That Are Way Cheaper in Canada

A lot of the discussion related to curbing runaway drug prices in the United States has focused on the importation of drugs from neighboring Canada.

Forbes: Why Patent Protection In The Drug Industry Is Out Of Control

In the United States, the patent protection process as it relates to the drug industry has been distorted by the political system, intense lobbying and large campaign contributions.

Bloomberg: Secret Rebates Erode Drugmaker Revenue, Industry Study Says

Branded drug companies’ share of total U.S. spending on their products is declining, in part because of an increase in secret rebates paid to middlemen, according to an analysis sponsored by an industry group that’s been seeking to deflect scrutiny of rising prices.

FiercePharma: Amid insulin market scrutiny, Novo faces class action alleging 'collusive price fixing'

While all of biopharma felt the sting of tough talk from President-elect Donald Trump on Wednesday, Novo Nordisk faced some fresh concerns of its own.

Governing: In Towns That Lost Most Obamacare Insurers, Premiums Are Still Competitive

People in this city had their pick of four health insurers last year when they shopped for policies during the Affordable Care Act’s open enrollment.

Fox News: Rising cost of diabetes care concerns patients and doctors

Edith Prentiss has Type 1 diabetes and needs to take insulin several times a day.

ABC7: Families feeling financial strain of diabetes

Finger pricks are no longer the painful part for Christie Lawrence — it's affording the rising cost of her diabetes.

Des Moines Register: Editorial: Handing money to generic drug makers won't stop price spikes

Isla Weston was two months old when doctors diagnosed her with a life-threatening parasitic infection in May 2015.

Fox 5: Rising cost of insulin concerns patients and doctors

A crisis could be on the horizon for some insulin-dependent diabetic patients.

13WHAM News: Soaring cost of life-saving drug becoming burden for diabetics

For diabetics, it is an added burden in dealing with the disease: skyrocketing prices for life-saving medications, including insulin.

USA Today: Insulin is getting really expensive

Since 2002, the cost of insulin has increased by almost 200 percent, according to a new study.

CNN: Prices for top-selling insulin are up 60%

The price of Lantus, one of the country's most popular insulin medicines, is up 60%.

Wall Street Journal: Drug Pricing Report Shows Limits of Transparency Push

A new Vermont law—the first of its kind in the U.S.—aims to shine a light on the murky world of prescription-drug pricing by requiring manufacturers to justify big increases.

Bloomberg: Pharma's Pricing Troubles Will Get Worse in 2017

The defining story of the past year in biopharma has been drug pricing, as much as the industry might wish otherwise.

Consumer Affairs: Diabetes tops U.S. spending on health care, heart disease is second

There's a lot of talk about the high cost of health care, but do you know which conditions contribute most to health care spending?

Reuters: Sanofi sues Novo Nordisk over diabetes drugs in the U.S.

France's Sanofi has filed a lawsuit in the United States accusing Novo Nordisk of falsely claiming that Sanofi insulin drugs would no longer be available for many U.S. patients so it could promote its competing drug.

CNBC: Diabetes costing Americans more than any other disease

About half of all health-care spending in the United States goes to treat a small group of diseases, according to new research.

USA Today: Soaring insulin prices prompt insurance shift

Many parents of diabetic children and adults suffering with type 1 or type 2 diabetes are bracing for changes in insurance coverage of their insulin next year, as prices of the vital medication continue to soar.

FiercePharma: It's the same song, but a brand new verse for 2017's drug-pricing debate

We won’t surprise anyone by saying that Topic No. 1 in pharma this year was drug pricing.

Los Angeles Times: Column: Soaring insulin prices are a case in point: A 'free market' in healthcare is doomed

A key feature of Republican plans to replace Obamacare is allowing market forces to boost innovation and competition among healthcare providers.

Baltimore Sun: 20 states sue 6 makers of generic drugs, alleging conspiracies to manipulate prices

Six makers of generic drugs artificially inflated and manipulated prices to reduce competition for an antibiotic and oral diabetes medication, 20 state attorneys general said in a federal lawsuit filed Thursday.

Medscape: Rising Insulin Costs in US Get Pushback as Basaglar Launches

The upward trajectory of insulin prices in the United States seems to be hitting a speed bump, as two of the biggest manufacturers are now pledging to restrain increases and offer discounts to patients.

The Hill: Managing diabetes is expensive — it's time to step up our game

More than 29 million Americans have diabetes — but a staggering quarter of them don't know it.

Business Insider: Some people spend as much on insulin as their mortgage — and drugmakers are taking note

For people living with Type 1 diabetes and some who live with Type 2, injections of insulin — a hormone that helps people absorb and process the sugar in food — are a necessary part of daily life.

Wall Street Journal: Eli Lilly Offers Discount for Insulin as Prices Soar

Eli Lilly & Co. said Tuesday it would discount the list prices of its insulin brands by as much as 40% for uninsured patients and others paying for the drugs largely out-of-pocket...

Washington Post: After years of price hikes, Eli Lilly announces a discount on insulin

Under pressure from politicians and patient groups, diabetes pharmaceutical giants have been taking action in recent weeks to limit the effect of rising insulin prices on patients.

Bloomberg: Lilly to Sell Insulin at 40% Discount to Cash-Paying Patients

Eli Lilly & Co. will bypass insurance companies to offer a 40 percent discount on its best-selling insulin products for patients who lack health coverage...

CBS 12: Why diabetes patients can’t buy generic insulin

As the nation’s number of diabetic patients grow, so does the need for insulin.

WNCT 9: Local diabetics seek cure for rising cost of insulin

Local health experts say the rising cost of insulin is a major issue impacting one in every five people in eastern North Carolina.

Endocrinology Advisor: American Diabetes Association Calls for Access to Affordable Insulin

In early November, Sen. Bernie Sanders, the Vermont Democrat, pointed out that certain insulins had risen from $21 a vial in 1996 to $255 a vial in 2016.

KIDY FOX: Insulin Prices Are Skyrocketing

A life-saving medication used to treat diabetes has increased in price more than 700 percent over the past 20 years.

WTAJ TV: Cost of life-saving drug soars

The American Diabetes Association says millions of Americans are paying a steep price to stay alive.

DiabetesMine: National Meeting Addresses Insulin Affordability and Access

Momentum seems to be building big time around the outrage over skyrocketing insulin prices, which are making this life-sustaining drug virtually unavailable to those who need it.

HealthDay: Insulin Prices Skyrocket, Putting Many Diabetics in a Bind

Insulin, a life-saving medication used to treat diabetes, was discovered nearly 100 years ago, yet the price of the drug has now spiked by 700 percent in just two decades.

Healio: ADA launches initiative, petition for affordable insulin

In response to the rising cost of insulin, the American Diabetes Association announced a resolution and petition that calls for transparency in the insulin supply chain...

WFMY News 2: Why Is Insulin Getting More Expensive?

Maybe it’s only fitting that nearly a century after a trio of scientists in Canada sold the patent rights on insulin for $3, millions of American diabetics now rely on a trio of drug manufacturers to supply them with a drug they need to stay alive.

Washington Post: American Diabetes Association calls on Congress to hold hearings on insulin prices

The American Diabetes Association's board of directors is calling on Congress to hold hearings to investigate dramatic increases in insulin prices and to take action to ensure that people have affordable access to the essential drug.

KUSA News 9: American Diabetes Association wants probe into soaring Insulin prices

The American Diabetes Association wants Congress to investigate what’s causing the cost of insulin to soar.

POLITICO Pulse: American Diabetes Association calls for congressional hearings on insulin pricing

Thursday's request by the ADA, accompanied by a resolution and petition that calls for increased transparency in the insulin supply chain, is an unusual move for a patient advocacy group...

American Journal of Managed Care: ADA Resolution Asks Congress to Investigate Insulin Prices

The American Diabetes Association (ADA) Board of Directors on Thursday passed a resolution asking Congress to investigate soaring insulin prices, which tripled between 2002 and 2013 and are blamed by experts for rising rates of diabetic ketoacidosis.

MedCity News: Insulin caught in the crossfire of drug pricing debate

Recent debates over skyrocketing drug prices are directly impacting diabetes patients, but it’s an extremely complex situation said Aaron Kowalski, chief mission officer at the Juvenile Diabetes Research Fund (JDRF).

Washington Post: Drugs for hepatitis C and diabetes drove Medicare spending in 2015

A hepatitis C treatment and a form of insulin led Medicare drug spending, adding up to more than $11 billion in 2015...

WebMD: Insulin Price Hikes Draw Blood, Criticism

First, the price of EpiPens drew fire. Now, it’s insulin’s turn.

Business Insider: Everyone wants a piece of the drug industry and it's one reason prices are rising so fast

Don’t just blame drug companies for rising prescription prices.

POLITICO Pro: Sanders, Cummings call for investigation into diabetes drug pricing

Sen. Bernie Sanders and Rep. Elijah Cummings called on the Justice Department and FTC to investigate potential collusion among drug companies on the rising prices of diabetes medicines.

NBC News: Is Insulin the New EpiPen? Families Facing Sticker Shock Over 400 Percent Price Hike

In the last eight years, the average price per milliliter of insulin has skyrocketed by over 200 percent.

Business Insider: Bernie Sanders is going after insulin makers over price hikes

Senator Bernie Sanders is going after insulin makers.

The Washington Post: Why Treating Diabetes Keeps Getting More Expensive

At first, the researchers who discovered insulin agonized about whether to patent the drug at all.

PBS NewsHour: The Insulin Market is Heading for a Shakeup. But Patients May Not Benefit

The insulin market, dominated by old drugs that have skyrocketed in price, is on the verge of a shakeup.

The Wall Street Journal: Insulin Prices Soar While Drugmakers’ Share Stays Flat

Insulin prices are soaring, creating pain for patients whose lives depend on the injectable drug—yet most of the revenue from the increases isn’t going to the drug manufacturers.

Bloomberg: Why Patients Pay $600 for Drugs That Cost $300

Robyn Curtis, a staff adviser at the University of Southern Mississippi in Hattiesburg, has a 13-year-old daughter with diabetes.

NBC News: Consumer Alert: Hundreds of Drugs Dropped from Some Prescription Plans

As businesses approach open enrollment, some prescription plans are dropping coverage on more than 200 commonly used drugs in an attempt to force drug makers to stop dramatic price hikes.

The Wall Street Journal: Drugmakers Point Finger at Middlemen for Rising Drug Prices

As U.S. drug prices rise, drugmakers are playing down their role, instead heaping blame on the middlemen who help determine how medicines are priced.

Business Insider: A 93-Year-Old Drug that Can Cost More Than a Mortgage Payment Tells Us Everything That's Wrong with American Healthcare

One reason Janine LePere is paying so much for insulin is that the LePere family has a high-deductible health plan.

TIME: Insulin Prices Are Skyrocketing, Too

The EpiPen isn’t the only life-saving medication that has experienced egregious price increases in the past decade...

WHEC News 10: It's not just EpiPens: Insulin prices forcing patients to make tough decisions

The rising price of EpiPens has been a large topic of discussion over the past week.

CBS MoneyWatch: Soaring Insulin Prices Have Diabetics Feeling the Pain

Insulin is fast becoming a medication that only the well-insured or well-heeled diabetic can afford.

Slate: Good Lord. Even the Price of Insulin Is Skyrocketing.

At this point, it’s getting hard to keep track of all the stories of drug companies jacking up the prices of prescription medications to nauseating heights for little identifiable reason... Insulin price gouging endangers lives and limbs of thousands of diabetics

The spike in prices for insulin in the United States is causing a crisis for patients, say doctors who specialize in treatment of diabetes.

Missoulian: Insulin price spike leaves diabetes patients in crisis

A massive spike in insulin prices is causing a health crisis for millions of diabetes patients who depend on the lifesaving drug, doctors say.

Montana Standard: Local perspective: Insulin dilemma daily concern

Ida Reighard of Butte, a registered nurse, has worked 17 years with diabetes patients and in diabetes education.

MedCity News: Infographic: Why does JAMA say insulin has tripled in price?

A new JAMA paper that says insulin prices have nearly tripled in a decade is making the internet rounds – and for good reason.

Consumer Reports: Is There a Cure for High Drug Prices?

Last August, Martin Shkreli, then the CEO of Turing Pharmaceuticals, did something considered so reprehensible that he was dubbed “the most hated man in America.”

Bloomberg: Decoding Big Pharma’s Secret Drug Pricing Practices

Health insurance companies buy prescription drugs the way U.S. consumers buy cars: There’s the sticker price (which few people actually pay) and there’s the negotiated price.

Connecticut Health I-Team: Low-Income Diabetics Paying High Price For Insulin

The high cost of insulin, which has risen by triple-digit percentages in the last five years, is endangering the lives of many diabetics who can’t afford the price tag, say Connecticut physicians who treat diabetics.

Reuters: Insulin cost in U.S. more than doubles between 2002-2013

The cost of the hormone insulin, one of the most important treatments for diabetes, rose nearly 200 percent between 2002 and 2013, according to a new study.

Reuters: Exclusive: Makers took big price increases on widely used U.S. drugs

Major drug companies took hefty price increases in the U.S., in some cases more than doubling listed charges, for widely used medications over the past five years, a Reuters analysis of proprietary data found.

Diabetes Forecast: The Rising Cost of Insulin

The cost of a vial of insulin starts with the pharmaceutical company and how it sets a price for insulin or any other drug.

Diabetic Lifestyle: Insulin Prices Skyrocketing

The wholesale price of a vial of Lantus has soared 513% since it was introduced in 2001.

The New York Times: Break Up the Insulin Racket

One of my patients — whom I will call Mrs. B — is a 78-year-old who has had Type 2 diabetes for over 30 years.

MarketWatch: Eli Lilly’s revenue boosted by jacking up cost of insulin for diabetics

Eli Lilly and Company increased its U.S. revenue by 15% for the fourth-quarter, but the rise may have come partly at the expense of patients with diabetes. Insulin price shock

Injectable insulin, which keeps some diabetics alive and keeps others out of serious health crises, has soared in price in the last few years.

New York Times: How to Decrease Prices for an Expensive Class of Drugs

Competition among generic drug makers pushes drug prices downward.

Business Insider: Why a lifesaving drug that's been around since 1923 is still unaffordable

An essential drug that has been on the market for decades still has a sticker price out of range for some patients who need it.